• A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease
• A loss-of-function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativa
• About a Rare Association Between Vulvar Dowling Degos Disease and HS
• Adapalene
• Altered Notch signalling in Dowling-Degos disease: a transcriptomic insight into disease pathogenesis
• Amantadine use in the French prospective NS-Park cohort
• An Algorithmic Approach Towards Diagnosis of Patients with Hereditary Reticulate Pigmentary Disorders- A narrative review
• Case Report: Infant-onset Degos disease with nervous system involvement and a literature review
• Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study
• Clinical Manifestation of Degos Disease: Painful Penile Ulcers
• Clinical Overlaps in Reticulate Pigmentary Disorders: A Study of Three Cases
• Contribution of MRI for the Early Diagnosis of Parkinsonism in Patients with Diagnostic Uncertainty
• Degos disease: A rare disease with a fatal outcome
• Deleterious effect of sustained neuroinflammation in pediatric traumatic brain injury
• Diagnostic criteria, epidemiology and assessment of patients with functional neurological disorders
• Dowling-Degos Disease
• Dowling-Degos Disease
• Dowling-Degos Disease in the Anogenital Region
• Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study
• Follicular Variant of Acquired Dermal Macular Hyperpigmentation: A Case Report
• Founder Variants in KRT5 and POGLUT1 Are Implicated in Dowling-Degos Disease
• French validation of the Quality of life in Essential Tremor Questionnaire (QUEST) and the Essential Tremor Embarrassment Assessment (ETEA)
• Functional neurological disorders: A clinical anthology
• Galli-Galli Disease: A Comprehensive Literature Review
• Haber's Syndrome: A Case Report
• In silico modelling of the function of disease-related CAZymes
• Inherited Reticulate Pigmentary Disorders
• Is the clinical phenotype impact the prognosis in dementia with Lewy bodies?
• KRT5 mutation regulate melanin metabolism through notch signalling pathway between keratinocytes and melanocytes
• Lymphomatoid Papulosis: A Case Report
• Malignant Atrophic Papulosis
• Malignant Atrophic Papulosis
• Malignant atrophic papulosis (Degos disease) with central nervous system involvement
• Malignant Atrophic Papulosis Presenting with Intestinal Perforation: A Case Report
• Malignant atrophic papulosis treated with eculizumab and hirudin: a fatal case report and literature review
• Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
• Neue Behandlungsoption bei Köhlmeier-Degos-Krankheit
• Trial of Botulinum Toxin for Isolated or Essential Head Tremor
• Tumor necrosis factor ALPHA Inhibitor Associated Kohlmeier-Degos Disease as a Novel Iatrogenic Paradigm That Underscores Excessive Type I Interferon in Its Pathogenesis
• Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease